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TEWL- transepidermal water loss 29 
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 ABSTRACT 51 
Transepidermal water loss (TEWL) is the most widely used objective measurement for 52 
assessing the barrier function of skin in healthy individuals but also patients with skin 53 
diseases that are associated with skin barrier dysfunction, such as atopic dermatitis (AD). 54 
TEWL is the quantity of condensed water that diffuses across a fixed area of stratum corneum 55 
(SC) to the skin surface per unit time. The water evaporating from the skin is measured using 56 
a probe that is placed in contact with the skin surface and contains sensors that detect changes 57 
in water vapour density. TEWL can be measured using an open-chamber, unventilated-58 
chamber or condenser-chamber device. It is a sensitive measure that is affected by properties 59 
of the surrounding microclimate such as environmental humidity, temperature, and airflow 60 
and should be measured under controlled conditions. TEWL varies significantly across 61 
different anatomical sites and also depends on sweat gland activity, skin temperature, and 62 
corneocyte properties. Here we describe how to optimally use TEWL measurements as a skin 63 
research tool in vivo and in vitro. 64 
 65 
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 INTRODUCTION 76 
The outer layer of the epidermis, the stratum corneum (SC), contributes to skin barrier 77 
properties and has many protective functions (Elias 2008), including contribution to the 78 
control of transcutaneous water loss. The movement of water across the SC is primarily 79 
controlled by flattened corneocytes surrounded by hydrophobic bilamellar lipids including 80 
ceramides, cholesterol, and free fatty acids. The permeability barrier function of the skin is 81 
critical and its impairment leads to downstream signals that aim to restore barrier 82 
homeostasis.  83 
 84 
Transepidermal water loss (TEWL) measurement is the most widely used objective 85 
measurement for assessing the barrier function of the skin (Fluhr et al. 2006). TEWL 86 
measures the quantity of water lost from inside the body by diffusion across the SC. Skin 87 
barrier dysfunction results in increased TEWL. Skin diseases in which the skin barrier is 88 
disturbed, such as atopic dermatitis (AD), contact dermatitis, psoriasis, and ichthyoses, are 89 
associated with elevated TEWL. 90 
 91 
TEWL as a measure of skin water barrier status has been validated in both humans and mice 92 
by correlating TEWL with absolute water loss determined gravimetrically (Fluhr et al. 2006). 93 
In addition to gauging water barrier function, in vivo TEWL measurements consistently 94 
correlate with the percutaneous absorption of topically applied compounds (Levin and 95 
Maibach 2005). As such, TEWL measurements can be seen as an indirect measure of skin 96 
permeability (both inside to outside and outside to inside), which is a function of skin barrier 97 
status. A stronger skin barrier, characterised by larger surface corneocytes, an increased 98 
number of corneocyte layers (increased path length across the SC), and/or improved inter-99 
corneocyte lamellar lipid matrices are linked to reduced TEWL (Damien and Boncheva 100 
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 2010). The molecular organization of the SC extracellular lipid matrix into a highly ordered 101 
lamellar bilayer structure is an important determinant of TEWL (Elias 2008). The proportion 102 
of SC composed of alpha-phase lipid bilayers inversely correlates with TEWL. Changes in 103 
the lipid matrix structure induced by environmental factors such as temperature and humidity 104 
may therefore be responsible for the differences in TEWL observed under these conditions 105 
(Damien and Boncheva 2010).  106 
 107 
 108 
TEWL MEASUREMENT 109 
TEWL is not measured directly, but inferred from measuring the change (or flux) in water 110 
vapour density at the skin surface compared with a point further away from the skin ((Nilsson 111 
1977). If water loss across the SC were zero, then the humidity in the air adjacent to the skin 112 
surface would be the same as ambient humidity. As water loss across the SC increases, the 113 
humidity next to the skin surface rises above ambient humidity. This creates a humidity 114 
gradient above the skin surface that is proportional to the SC water loss (Imhof et al. 2009). 115 
Water vapour density measurements are taken over a fixed area of SC in a fixed time period, 116 
and the units for TEWL are stated as grams of water per square metre per hour (g m-2 h-1). 117 
 118 
TEWL can be measured using an open-chamber device, an unventilated-chamber device or a 119 
condenser-chamber device. Because of the sensitivity and variability in measurement of 120 
TEWL, usually three or more readings are taken in order to calculate a mean value. 121 
 122 
 123 
 124 
TEWL DEVICES 125 
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 Open-chamber devices consist of a hollow cylinder that is placed in contact with the skin 126 
(Nilsson 1977). Water vapour from the skin surface diffuses through the chamber and out into 127 
the ambient atmosphere. The humidity gradient is calculated from temperature and relative 128 
humidity readings from two sensors that are fixed at different distances from the skin surface 129 
(Figure 1a). An advantage of open-chamber devices is that they do not occlude the skin and 130 
therefore leave the cutaneous microclimate relatively undisturbed. One of their major 131 
limitations, however, is that they are vulnerable to environmental influences, such as 132 
disturbance from ambient air movements.  133 
 134 
Unventilated-chamber devices consist of a chamber with a closed upper end, which protects 135 
from ambient air movement disturbances. Water vapour from the skin surface collects in the 136 
chamber causing the humidity to rise with time. Sensors in the chamber measure the rate of 137 
increase in relative humidity (Figure 1b). This method requires the chamber to be lifted from 138 
the skin after every reading to allow the accumulated water vapour to escape. These devices 139 
therefore cannot be used for continuous TEWL measurement. 140 
 141 
The more recently developed condenser-chamber device has become increasingly used, as it 142 
provides a dynamic reading of the transcutaneous water loss (Imhof et al. 2009). The upper 143 
end of the chamber is closed by a condenser that is cooled below the freezing point of water. 144 
The condenser removes water vapour from the chamber, enabling continuous measurements 145 
to be made without the need to interrupt the measurement to allow the water vapour to escape. 146 
The condenser also controls the microclimate within the chamber by protecting from ambient 147 
air movement and controlling the humidity. The water vapour density is measured in a similar 148 
way to open chamber devices by separately spaced sensors in the chamber (Figure 1c). 149 
 150 
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 A number of studies have compared the performance of different TEWL devices and find that 151 
results show good correlation (Fluhr et al. 2006; Farahmand et al. 2009). However, a small 152 
comparative study of an open-chamber system with an unventilated-chamber system and a 153 
condenser-chamber system found that the condenser-chamber system was the only device that 154 
could detect the effect of tape-stripping on TEWL and the only device that could discriminate 155 
between the effects of moisturiser and petrolatum on skin barrier integrity (Farahmand et al. 156 
2009), suggesting that the condenser-chamber method gives greater sensitivity. 157 
 158 
 159 
FACTORS AFFECTING TEWL 160 
TEWL has been shown to vary significantly at different anatomical sites within an individual 161 
(Kottner et al. 2013). TEWL is high at the palms, soles, axillae and forehead and low at the 162 
calf and forearm. The increased TEWL at sites such as the palms and soles is linked to the 163 
low sebaceous lipid content at these sites (Brancaleon et al. 2001). Regional differences in 164 
TEWL may also be due to differences in sweat gland activity, occlusion, skin temperature, 165 
thickness, and microvasculature as well as corneocyte size, maturity, and shedding. In adults, 166 
some studies suggest that TEWL decreases with age but others have found no association 167 
between TEWL and age (Kottner et al. 2013; Zouboulis et al. 2018). Some studies have found 168 
TEWL differences in different ethnic groups. For instance, TEWL is higher in black and 169 
Asian skin compared to Caucasian skin (Kompaore et al. 1993). Skin care practices also affect 170 
TEWL. Detergents such as sodium lauryl sulfate can damage the skin barrier and lead to 171 
increased TEWL, whereas emollients transiently occlude the skin and reduce TEWL (Danby 172 
et al. 2016). Skin surface temperature and sweating additionally alter TEWL (Pinnagoda et al. 173 
1990). Studies have also shown seasonal variation in TEWL and that TEWL is affected by 174 
circadian rhythm and sun exposure (Le Fur et al. 2001; Liu et al. 2010). 175 
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  176 
 177 
TEWL MEASUREMENT IN VIVO 178 
Guidelines have been developed to help control external factors affecting TEWL in research 179 
studies and achieve consistency and accuracy (Pinnagoda et al. 1990; Rogiers and Group 180 
2001). The selection of the skin area to be tested is important and the volar forearm is the site 181 
used most often for dermatological studies. There should be an interval of at least 12 hours 182 
between application of topical skin products and TEWL measurement and at least 2 hours 183 
between skin washing and TEWL measurement. A room of temperature 18-21°C and relative 184 
humidity 40-60% should be used and direct light avoided. Subjects should acclimatize to the 185 
environment for 20-30 minutes before TEWL measurement. TEWL measurements should 186 
ideally be taken at the same time of day, during the same season and avoiding the summer 187 
months.  188 
 189 
Calibration of TEWL instruments is essential and depends on the device and manufacturer 190 
(Pinnagoda et al. 1990; Imhof et al. 2009). Due to the differences in TEWL measurement 191 
devices and study designs, there is a lack of consensus regarding reference TEWL values. It is 192 
therefore recommended that baseline TEWL measurements are recorded and that results are 193 
interpreted as a relative change (Rogiers and Group 2001). 194 
 195 
In addition to the use of basal TEWL to assess the undisturbed permeability of the skin 196 
barrier, TEWL measurements conducted in conjunction with controlled skin barrier 197 
perturbation by tape-stripping is used to measure skin barrier integrity (Danby et al. 2011). 198 
Tape-stripping is a procedure where the uppermost layers of corneocytes are peeled away 199 
from the surface using standardized adhesive discs, such as D-Squame discs (CuDerm, TX). 200 
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 Where the skin displays reduced structural integrity, tape-stripping removes more 201 
corneocytes, leading to a more rapid disruption of the skin barrier and consequently a sharper 202 
increase in TEWL with each consecutive stripping. Initially, healthy skin is fairly insensitive 203 
to tape-stripping, demonstrating the capacity of the skin to withstand mild perturbation. 204 
Disrupted skin and skin with a low structural integrity exhibit greater changes in TEWL 205 
underpinning the increased sensitivity of the technique. The area under the curve for TEWL 206 
measurements made over a defined number of tape strippings can be used to reflect the 207 
overall integrity of the SC (Figure 2). Quantifying the amount of protein removed by each 208 
tape strip disc can similarly be used to reflect the cohesiveness of the SC (Danby et al. 2016). 209 
Combining both the TEWL and protein data can be used to estimate the thickness of the SC 210 
by utilizing Fick’s first law of diffusion (Bashir et al. 2001). 211 
 212 
The measurement of skin barrier recovery rates after barrier impairment can reveal skin 213 
barrier differences that are not seen with basal TEWL measurement alone. For instance, 214 
ageing and stress lead to delayed skin barrier recovery whereas darkly pigmented skin, 215 
independent of race, recovers more quickly after tape stripping than lightly pigmented skin 216 
(Ghadially et al. 1995; Reed et al. 1995; Muizzuddin et al. 2003). Barrier recovery kinetics 217 
can also be used to assess response to topical treatments and to identify the metabolic 218 
processes that maintain a functioning skin barrier (Feingold 2009). 219 
 220 
 221 
 222 
TEWL MEASUREMENT IN VITRO 223 
TEWL has also been used as a quantitative parameter to assess skin barrier integrity and 224 
function in explanted skin (Sundaram et al. 2016; Döge et al. 2017; Zhang et al. 2018), skin 225 
9
 barrier formation in cultured skin models (Nolte et al. 1993) and epidermal models (Hatano et 226 
al. 2005; Kuntsche et al. 2008) in vitro.  227 
 228 
TEWL may be measured on cultured samples directly 229 
(https://www.biox.biz/Products/ProductDetails.php), or after mounting in a Franz cell 230 
(http://www.courage-khazaka.de/index.php/en/products/scientific/382-tewitro-e) or with 231 
adaptation to allow multiple wells to be measured simultaneously (http://www.courage-232 
khazaka.de/index.php/en/products/scientific/382-tewitro-e). TEWL measurement has been 233 
shown to directly correlate with the measurement of tritiated water flux, while being a safer 234 
and more user-friendly measurement (Elmahjoubi et al. 2009).   235 
 236 
One advantage of TEWL measurement in vitro is that it is less sensitive to the variable of 237 
water loss by sweating that occurs in vivo, but repeated measurements show variation as the 238 
sample equilibrates to ambient temperature and humidity outside the tissue culture incubator, 239 
so equilibration time should be standardised across replicate experiments.   240 
 241 
The absolute TEWL measurement shows variability between replicate experiments and the 242 
different models give different TEWL measurements (Figure 3), reflecting in part the 243 
different distances between water source (media and/or dermis) and the epidermal surface. 244 
Direct comparisons between experimental measurements are therefore not appropriate and it 245 
is important to include within-experiment controls for comparison. 246 
 247 
CLINICAL APPLICATIONS OF TEWL MEASUREMENT 248 
Skin barrier dysfunction and increased TEWL are major pathologic features of AD (Elias 249 
2008; Flohr et al. 2010) . TEWL is used as a research tool to objectively assess skin barrier 250 
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 function, and it can be robustly correlated with the severity of AD and response to treatment, 251 
leading to the inclusion of the parameter in some AD severity scores (Pinnagoda et al. 1990; 252 
Rogiers and Group 2001; Chamlin et al. 2002; Sugarman et al. 2003) . Filaggrin is a key 253 
component of the epidermal skin barrier and up to 50% of patients with moderate-severe AD 254 
are heterozygous for one of the filaggrin gene (FLG) loss-of-function mutations (Baurecht et 255 
al. 2007) . Studies have shown that at birth, there is no difference in TEWL between FLG 256 
mutation and FLG wild-type groups (Kelleher et al. 2015; Horimukai et al. 2016). However at 257 
2 months, 3 months, and 6 months of age, those carrying a FLG mutation have a significantly 258 
higher TEWL than those without (Flohr et al. 2010; Kelleher et al. 2015). Importantly, TEWL 259 
was found to be elevated in infants with FLG null mutations even without clinical AD, 260 
suggesting that skin barrier impairment may precede the clinical manifestation of AD. 261 
Kelleher et al and Horimukai et al have demonstrated that TEWL measured during the first 262 
days of life can predict the development of AD in infancy, independent of FLG status. These 263 
findings suggest that TEWL could potentially be used to identify neonates at increased risk of 264 
AD and help to guide prevention strategies, for instance with regular emollient application.  265 
 266 
 267 
CONCLUSIONS 268 
TEWL is a research tool that enables objective and non-invasive measurement of one aspect 269 
of skin barrier function in dermatological research. TEWL elevation is a hallmark of AD and 270 
may precede clinical manifestation of the disease suggesting that TEWL measurement may be 271 
useful in guiding AD prevention strategies. 272 
 273 
 274 
 275 
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 278 
SUMMARY POINTS 279 
 TEWL measurement is used to objectively assess the barrier function of the skin in 280 
vivo and in vitro. 281 
 Skin diseases in which the skin barrier is disturbed, such as atopic dermatitis (AD), 282 
contact dermatitis, and psoriasis, are associated with elevated TEWL. 283 
 TEWL can be measured using an open-chamber device, an unventilated-chamber 284 
device, or a condenser-chamber device. 285 
 TEWL is affected by properties of the surrounding microclimate such as 286 
environmental humidity, temperature, and airflow, and should be measured under 287 
controlled conditions. 288 
 289 
 290 
 291 
 292 
 293 
 294 
 295 
MULTIPLE CHOICE QUESTIONS 296 
1. How is TEWL measured? 297 
A. By measuring the volume of water on the surface of the skin  298 
B. By measuring absolute water loss from the skin gravimetrically 299 
12
 C. By measuring relative humidity and temperature at the skin surface to calculate the change 300 
in water vapour density  301 
D. By measuring evaporation of water from the skin to the atmosphere 302 
 303 
2. What advantages do condenser-chamber TEWL devices have over unventilated and 304 
open-chamber devices? 305 
A. Water can diffuse out of the chamber into the atmosphere. 306 
B. Continuous TEWL measurements can be made and disturbance from ambient air 307 
movements is minimised. 308 
C. The chamber is closed allowing water vapour to accumulate in the chamber. 309 
D. Individual TEWL measurements can be made faster. 310 
 311 
3. What are the suggested conditions for TEWL measurement? 312 
A. Room temperature 18-21°C, relative humidity 40-60%, in direct light, and subjects should 313 
acclimatize to the environment for 20-30 minutes before TEWL measurement. 314 
B. Room temperature 18-21°C, relative humidity 20-30%, avoid direct light, and subjects 315 
should acclimatize to the environment for 20-30 minutes before TEWL measurement. 316 
C. Room temperature 18-21°C, relative humidity 20-30%, avoid direct light, and take 317 
measurement as soon as subject enters the testing environment. 318 
D. Room temperature 18-21°C, relative humidity 40-60%, avoid direct light, and subjects 319 
should acclimatize to the environment for 20-30 minutes before TEWL measurement. 320 
 321 
4. Which body regions have the highest TEWL? 322 
A. Palms, soles, axillae, and forehead 323 
B. Calves and forearms 324 
13
 C. Antecubital fossae 325 
D. Abdomen, chest, and back 326 
 327 
5. Which statement is true regarding TEWL in AD? 328 
A. At 3 months of age, FLG mutation carrying infants do not have increased TEWL. 329 
B. TEWL is increased at birth in FLG mutation carrying neonates compared to FLG wild-type 330 
neonates. 331 
C. TEWL is not a parameter in any AD severity scores 332 
D. TEWL measured during the first days of life can predict the development of AD in 333 
infancy. 334 
 335 
ANSWERS 336 
1. How is TEWL measured? 337 
A. By measuring the volume of water on the surface of the skin  338 
B. By measuring absolute water loss from the skin gravimetrically 339 
C. By measuring relative humidity and temperature at the skin surface to calculate the 340 
change in water vapour density  341 
Explanation: 342 
As water loss across the SC increases, the humidity next to the skin surface rises and creates a 343 
humidity gradient that is proportional to the SC water loss. TEWL is inferred from measuring 344 
the change (or flux) in water vapour density at the skin surface compared with a point further 345 
away from the skin. 346 
D. By measuring evaporation of water from the skin to the atmosphere 347 
 348 
 349 
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 2. What advantages do condenser-chamber TEWL devices have over unventilated and 350 
open-chamber devices? 351 
A. Water can diffuse out of the chamber into the atmosphere. 352 
B. Continuous TEWL measurements can be made and disturbance from ambient air 353 
movements is minimised. 354 
Explanation:  355 
Condenser-chamber TEWL devices are closed by a condenser that is cooled below the 356 
freezing point of water. The condenser removes water vapour from the chamber, enabling 357 
continuous measurements to be made without the need to interrupt the measurement to allow 358 
the water vapour to escape. The condenser also controls the microclimate within the chamber 359 
by protecting from ambient air movement and controlling the humidity 360 
C. The chamber is closed allowing water vapour to accumulate in the chamber. 361 
D. Individual TEWL measurements can be made faster. 362 
 363 
3. What are the suggested conditions for TEWL measurement? 364 
A. Room temperature 18-21°C, relative humidity 40-60%, in direct light, and subjects should 365 
acclimatize to the environment for 20-30 minutes before TEWL measurement. 366 
B. Room temperature 18-21°C, relative humidity 20-30%, avoid direct light, and subjects 367 
should acclimatize to the environment for 20-30 minutes before TEWL measurement. 368 
C. Room temperature 18-21°C, relative humidity 20-30%, avoid direct light, and take 369 
measurement as soon as subject enters the testing environment. 370 
D. Room temperature 18-21°C, relative humidity 40-60%, avoid direct light, and 371 
subjects should acclimatize to the environment for 20-30 minutes before TEWL 372 
measurement. 373 
Explanation:  374 
15
 Ambient temperature, humidity and light exposure have all be shown to affect TEWL 375 
measurement. Consensus guidelines suggest controlling these factors to achieve consistency 376 
and accuracy in TEWL measurement. 377 
 378 
4. Which body regions have the highest TEWL? 379 
A. Palms, soles, axillae, and forehead 380 
Explanation: 381 
Studies have found TEWL is highest at the palms, soles, axillae and forehead. The increased 382 
TEWL at sites such as the palms and soles is linked to the low sebaceous lipid content at 383 
these sites (Brancaleon et al. 2001). Regional differences in TEWL may also be due to 384 
differences in sweat gland activity, occlusion, skin temperature, thickness, and 385 
microvasculature as well as corneocyte size, maturity, and shedding. 386 
B. Calves and forearms 387 
C. Antecubital fossae 388 
D. Abdomen, chest, and back 389 
 390 
5. Which statement is true regarding TEWL in AD? 391 
A. At 3 months of age, FLG mutation carrying infants do not have increased TEWL. 392 
B. TEWL is increased at birth in FLG mutation carrying neonates compared to FLG wild-type 393 
neonates. 394 
C. TEWL is not a parameter in any AD severity scores 395 
D. TEWL measured during the first days of life can predict the development of AD in 396 
infancy. 397 
Explanation: 398 
16
 Kelleher et al and Horimukai et al showed that TEWL measured during the first days of life 399 
can predict the development of AD in infancy, independent of FLG status. These findings 400 
suggest that TEWL could potentially be used to identify neonates at increased risk of AD and 401 
help to guide prevention strategies, for instance with regular emollient application.  402 
 403 
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FIGURE LEGENDS  525 
Figure 1. TEWL devices. (a) Open-chamber TEWL device. A hollow cylinder is placed in 526 
contact with the skin and water vapour diffuses through the open-chamber. Spatially 527 
separated temperature and relative humidity sensors detect the humidity gradient. (b) 528 
Unventilated-chamber TEWL device. The upper end of the chamber is closed resulting in 529 
water vapour collecting in the chamber. The temperature and relative humidity sensors detect 530 
the rate of increase of relative humidity. (c) Condenser-chamber TEWL device. The upper 531 
end of the chamber is closed by a condenser that removes water vapour from the chamber 532 
enabling continuous TEWL measurements to be recorded. Water vapour density is measured 533 
by sensors in the chamber and condenser. 534 
 535 
Figure 2. TEWL measurement in conjunction with controlled skin barrier perturbation by 536 
tape-stripping is used to measure skin barrier integrity in AD research. The area under the 537 
curve for TEWL measurements made over a defined number of tape strippings can be used to 538 
reflect the overall integrity of the SC. 539 
 540 
Figure 3. In-vitro TEWL measurement from isolated human epidermis and rat epidermal 541 
keratinocyte organotypic cell culture epidermis (ROC) was used to determine the occlusive 542 
22
 properties of lipid nanoparticle formulations (MCT, D116, CM/CN, GMO) (n = 3-4) 543 
(reprinted from Kuntsche et al. 2008). 544 
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